New driver mutations in non-small-cell lung cancer - PubMed (original) (raw)
Review
New driver mutations in non-small-cell lung cancer
William Pao et al. Lancet Oncol. 2011 Feb.
Abstract
Treatment decisions for patients with lung cancer have historically been based on tumour histology. Some understanding of the molecular composition of tumours has led to the development of targeted agents, for which initial findings are promising. Clearer understanding of mutations in relevant genes and their effects on cancer cell proliferation and survival, is, therefore, of substantial interest. We review current knowledge about molecular subsets in non-small-cell lung cancer that have been identified as potentially having clinical relevance to targeted therapies. Since mutations in EGFR and KRAS have been extensively reviewed elsewhere, here, we discuss subsets defined by so-called driver mutations in ALK, HER2 (also known as ERBB2), BRAF, PIK3CA, AKT1, MAP2K1, and MET. The adoption of treatment tailored according to the genetic make-up of individual tumours would involve a paradigm shift, but might lead to substantial therapeutic improvements.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
- Rare mutations in non-small-cell lung cancer.
D'Arcangelo M, D'Incecco A, Cappuzzo F. D'Arcangelo M, et al. Future Oncol. 2013 May;9(5):699-711. doi: 10.2217/fon.13.16. Future Oncol. 2013. PMID: 23647298 Review. - Going beyond EGFR.
Zimmermann S, Peters S. Zimmermann S, et al. Ann Oncol. 2012 Sep;23 Suppl 10:x197-203. doi: 10.1093/annonc/mds319. Ann Oncol. 2012. PMID: 22987962 - Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer.
Kobayashi M, Sonobe M, Takahashi T, Yoshizawa A, Ishikawa M, Kikuchi R, Okubo K, Huang CL, Date H. Kobayashi M, et al. Anticancer Res. 2011 Dec;31(12):4619-23. Anticancer Res. 2011. PMID: 22199339 - A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations.
Alrifai D, Popat S, Ahmed M, Gonzalez D, Nicholson AG, Parcq Jd, Benepal T. Alrifai D, et al. Lung Cancer. 2013 Jun;80(3):339-40. doi: 10.1016/j.lungcan.2013.02.002. Epub 2013 Mar 15. Lung Cancer. 2013. PMID: 23499398 - New targetable oncogenes in non-small-cell lung cancer.
Oxnard GR, Binder A, Jänne PA. Oxnard GR, et al. J Clin Oncol. 2013 Mar 10;31(8):1097-104. doi: 10.1200/JCO.2012.42.9829. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401445 Free PMC article. Review.
Cited by
- RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms.
Yang X, Wu H. Yang X, et al. J Hematol Oncol. 2024 Nov 9;17(1):108. doi: 10.1186/s13045-024-01631-9. J Hematol Oncol. 2024. PMID: 39522047 Free PMC article. Review. - Maximizing Postoperative Success in NSCLC: The Critical Role of Multidisciplinary Collaboration.
Zhao R, Ma X, Zhang J. Zhao R, et al. Ann Surg Oncol. 2024 Dec;31(13):9366-9367. doi: 10.1245/s10434-024-16234-4. Epub 2024 Sep 14. Ann Surg Oncol. 2024. PMID: 39277545 No abstract available. - Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition.
Jeong JY, Bafor AE, Freeman BH, Chen PR, Park ES, Kim E. Jeong JY, et al. Biomedicines. 2024 Aug 7;12(8):1795. doi: 10.3390/biomedicines12081795. Biomedicines. 2024. PMID: 39200259 Free PMC article. Review. - The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions.
Rina A, Maffeo D, Minnai F, Esposito M, Palmieri M, Serio VB, Rosati D, Mari F, Frullanti E, Colombo F. Rina A, et al. Cancers (Basel). 2024 Aug 19;16(16):2882. doi: 10.3390/cancers16162882. Cancers (Basel). 2024. PMID: 39199653 Free PMC article. Review. - Changing profile of lung cancer clinical characteristics in China: Over 8-year population-based study.
Xu K, Wang H, Li S, Zhao L, Liu X, Liu Y, Ye L, Liu X, Li L, He Y. Xu K, et al. Chin Med J Pulm Crit Care Med. 2023 Sep 15;1(3):188-194. doi: 10.1016/j.pccm.2023.08.006. eCollection 2023 Sep. Chin Med J Pulm Crit Care Med. 2023. PMID: 39171125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous